DATE: July 19, 2017
TIME: 7:00am PT, 10:00am ET, 4:00pm CET
According to a recent report, 79% of FDA 483 Warning Letters issued in 2016 cited data integrity. In their guidance on data integrity and compliance with CGMP, the FDA issued their ALCOA definition of data integrity. This seminar will discuss ALCOA using cleanroom environmental monitoring data collection in the pharmaceutical industry as an example.
Medical Laboratory Technician6%
Clinical Laboratory Scientist3%
Contract Research Organization (Cro)2%
Life Science Company2%
Medical Device Company2%